Daewoong Pharmaceutical's 'Nabota' and 'Violet'

Daewoong Pharmaceutical's 'Nabota' and 'Violet'

View original image

[Asia Economy Reporter Chunhee Lee] Daewoong Pharmaceutical announced on the 31st that it held the 'Doctors Dermatology Network x Daewoong Pharmaceutical Live Seminar' at Doctors Dermatology Sinsa Branch on the 28th.


This seminar shared various and effective treatment methods using 'Nabota' and 'Violet' with multiple branches belonging to the dermatology specialist network hospitals. A total of 19 participants from 9 branches of Doctors Dermatology shared their treatment experiences and know-how.


Sung Hyun-cheol, head of Doctors Dermatology Sinsa Branch, led the session on 'Know-how of Combination Treatments Using Violet,' sharing expertise on how to perform Violet treatments effectively and safely. Following this, Go Beom-jun, head of Gongdeok Branch, joined to provide a 'Live Demonstration Using Violet and Nabota,' creating a practical learning opportunity utilizing Nabota and Violet.


Nabota, a botulinum toxin developed independently by Daewoong Pharmaceutical and approved by the U.S. Food and Drug Administration (FDA), is a product proven safe and effective even with long-term and repeated treatments. Currently, it holds cosmetic indications for improving glabellar lines and crow's feet, and therapeutic indications for upper limb spasticity after stroke and blepharospasm. Recently, it completed clinical trials for benign masseter hypertrophy (square jaw) and is applying for product approval, expanding its indications.


Violet, Daewoong Pharmaceutical's second medical aesthetic lineup, is an injectable for submental fat reduction launched in October last year. Its main ingredient, deoxycholic acid, has the advantage of a long-lasting effect due to its irreversible fat cell destruction mechanism.



Park Sung-soo, Vice President of Daewoong Pharmaceutical, said, “Following Nabota, with the launch of Violet, we are becoming a global medical aesthetic company,” adding, “We will continue to create academic exchange opportunities where more medical professionals can share effective and safe treatment methods through various marketing activities and research.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing